Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective studySimona Doniņa, A. Muceniece, Dite Venskus et al.|Melanoma Research|2015Cited by 125
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir<sup>®</sup> therapy: A case reportElizabete Pumpure, Simona Doniņa, Pēteris Alberts et al.|Clinical Case Reports|2020Cited by 5
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus RigvirIngrīda Čēma, Pēteris Alberts, Regīna Kleina et al.|The Permanente Journal|2022Cited by 5